North America Nicotine Replacement Therapy Market Size & Outlook

The nicotine replacement therapy market in North America is expected to reach a projected revenue of US$ 41,468.7 million by 2030. A compound annual growth rate of 13.1% is expected of North America nicotine replacement therapy market from 2024 to 2030.
Revenue, 2023 (US$M)
$17,506.3
Forecast, 2030 (US$M)
$41,468.7
CAGR, 2024 - 2030
13.1%
Report Coverage
North America

North America nicotine replacement therapy market, 2018-2030 (US$M)

North

North America nicotine replacement therapy market highlights

  • The North America nicotine replacement therapy market generated a revenue of USD 17,506.3 million in 2023.
  • The market is expected to grow at a CAGR of 13.1% from 2024 to 2030.
  • In terms of segment, nicotine replacement therapy was the largest revenue generating product in 2023.
  • Nicotine Replacement Therapy is the most lucrative product segment registering the fastest growth during the forecast period.


North America data book summary

Market revenue in 2023USD 17,506.3 million
Market revenue in 2030USD 41,468.7 million
Growth rate13.1% (CAGR from 2023 to 2030)
Largest segmentNicotine replacement therapy
Fastest growing segmentNicotine Replacement Therapy
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNicotine Replacement Therapy
Key market players worldwideCipla Ltd DR, Pfizer Inc, Philip Morris International Inc, British American Tobacco, Japan Tobacco Inc, Imperial Brands PLC, Johnson & Johnson


Other key industry trends

  • In terms of revenue, North America region accounted for 25.3% of the global nicotine replacement therapy market in 2023.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 99,743.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Nicotine Replacement Therapy Market Scope

Nicotine replacement therapy market segmentation & scope
Nicotine Replacement Therapy
E-cigarettes
Heat-not-burn tobacco products
Distribution Channel
Online
Offline
Countries
U.S.
Canada
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Mexico
Brazil
South Africa
Saudi Arabia
UK
Argentina
Kuwait
UAE

Nicotine Replacement Therapy Market Companies

Name Profile # Employees HQ Website

North America nicotine replacement therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nicotine replacement therapy market will help companies and investors design strategic landscapes.


Nicotine replacement therapy was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America nicotine replacement therapy market based on nicotine replacement therapy covering the revenue growth of each sub-segment from 2018 to 2030.


Growth of NRT market in North America can be attributed to various factors, including the growing burden of diseases associated with smoking and the increase in number of favorable government initiatives. Moreover, increasing adoption of e-cigarettes and heated tobacco products is expected to positively impact North America’s nicotine replacement therapy market.

The major tobacco companies in North America are focusing on product launches. Two of the major players operating in this market are GlaxoSmithKline plc. and Philip Morris Products S.A. The local presence globally leading companies is expected to increase the availability of alternatives in the region.

The presence of highly influential regulatory entities in North American countries is expected to foster the development of novel treatments in the near future. This is mainly due to the fact that these entities play a pivotal role in creating awareness among the people about the potential of treatments and supportive care in the management of smoking cessation.

Reasons to subscribe to North America nicotine replacement therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America nicotine replacement therapy market databook

  • Our clientele includes a mix of nicotine replacement therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America nicotine replacement therapy market , including forecasts for subscribers. This continent databook contains high-level insights into North America nicotine replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America nicotine replacement therapy market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more